Onkar Bedi

898 total citations
25 papers, 626 citations indexed

About

Onkar Bedi is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Onkar Bedi has authored 25 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Physiology. Recurrent topics in Onkar Bedi's work include Liver Disease Diagnosis and Treatment (9 papers), Diet, Metabolism, and Disease (5 papers) and Diet and metabolism studies (4 papers). Onkar Bedi is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Diet, Metabolism, and Disease (5 papers) and Diet and metabolism studies (4 papers). Onkar Bedi collaborates with scholars based in India, United States and Qatar. Onkar Bedi's co-authors include Puneet Kumar, Pawan Krishan, Veena Dhawan, Nirupma Trehanpati, Gayatri Ramakrishna, Rahul Deshmukh, Manisha Gupta, Shubham Sharma, Sachin Kumar and Gaaminepreet Singh and has published in prestigious journals such as Biochemical and Biophysical Research Communications, European Journal of Pharmacology and Frontiers in Cellular and Infection Microbiology.

In The Last Decade

Onkar Bedi

25 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Onkar Bedi India	14	184	144	99	98	94	25	626
Samar A. Antar Egypt	14	264 1.4×	82 0.6×	120 1.2×	65 0.7×	83 0.9×	25	816
Premila Abraham India	23	221 1.2×	98 0.7×	80 0.8×	70 0.7×	83 0.9×	53	1.2k
Kuan‐Ho Lin Taiwan	16	274 1.5×	175 1.2×	64 0.6×	60 0.6×	140 1.5×	39	788
Sara Paone Italy	13	173 0.9×	93 0.6×	100 1.0×	117 1.2×	60 0.6×	17	636
Kaoru Arii Japan	18	176 1.0×	111 0.8×	179 1.8×	54 0.6×	144 1.5×	40	1.1k
Ahmed E. Khodir Egypt	19	397 2.2×	86 0.6×	53 0.5×	58 0.6×	56 0.6×	31	789
Sahar K. Hegazy Egypt	13	314 1.7×	65 0.5×	109 1.1×	66 0.7×	88 0.9×	36	695
Anna Hernández‐Aguilera Spain	20	362 2.0×	264 1.8×	121 1.2×	203 2.1×	172 1.8×	69	1.1k
Maryam Teimouri Iran	14	219 1.2×	194 1.3×	97 1.0×	145 1.5×	41 0.4×	27	620
Thomas J. Velenosi Canada	19	417 2.3×	145 1.0×	77 0.8×	192 2.0×	91 1.0×	31	973

Countries citing papers authored by Onkar Bedi

Since Specialization

Citations

This map shows the geographic impact of Onkar Bedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Onkar Bedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Onkar Bedi more than expected).

Fields of papers citing papers by Onkar Bedi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Onkar Bedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Onkar Bedi. The network helps show where Onkar Bedi may publish in the future.

Co-authorship network of co-authors of Onkar Bedi

This figure shows the co-authorship network connecting the top 25 collaborators of Onkar Bedi. A scholar is included among the top collaborators of Onkar Bedi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Onkar Bedi. Onkar Bedi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Madaan, Reecha, Onkar Bedi, Gabriela Figueroa‐González, et al.. (2025). Targeting the Hippo/YAP Pathway: A Promising Approach for Cancer Therapy and Beyond. MedComm. 6(9). e70338–e70338. 1 indexed citations

Bedi, Onkar, V. T. Sapra, Manish Kumar, & Pawan Krishan. (2024). Newer mitochondrial dynamics and their role of calcium signalling in liver regeneration. Mitochondrion. 79. 101969–101969. 1 indexed citations

Bedi, Onkar, et al.. (2022). Histopathological and molecular links of COVID-19 with novel clinical manifestations for the management of coronavirus-like complications. Inflammopharmacology. 30(4). 1219–1257. 3 indexed citations

Bedi, Onkar, et al.. (2022). Proposed hypothesis of GSK-3 β inhibition for stimulating Wnt/β-catenin signaling pathway which triggers liver regeneration process. Naunyn-Schmiedeberg s Archives of Pharmacology. 395(3). 377–380. 7 indexed citations

Yadav, Vipin K., Rakhi Maiwall, Archana Rastogi, et al.. (2022). Metabolomic analysis shows dysregulation in amino acid and NAD+ metabolism in palmitate treated hepatocytes and plasma of non-alcoholic fatty liver disease spectrum. Biochemical and Biophysical Research Communications. 643. 129–138. 11 indexed citations

Bedi, Onkar, et al.. (2022). A review: traditional herbs and remedies impacting pathogenesis of Parkinson’s disease. Naunyn-Schmiedeberg s Archives of Pharmacology. 395(5). 495–513. 8 indexed citations

Gupta, Manisha, Pawan Krishan, Amarjot Kaur, et al.. (2021). Mechanistic and physiological approaches of fecal microbiota transplantation in the management of NAFLD. Inflammation Research. 70(7). 765–776. 17 indexed citations

Goyal, RK, et al.. (2021). Molecular and pathobiological involvement of fetuin-A in the pathogenesis of NAFLD. Inflammopharmacology. 29(4). 1061–1074. 24 indexed citations

Kumar, Puneet, Mandeep Kumar, Onkar Bedi, et al.. (2021). Role of vitamins and minerals as immunity boosters in COVID-19. Inflammopharmacology. 29(4). 1001–1016. 94 indexed citations

10.

Kaur, Amarjot, et al.. (2020). Pathobiological and molecular connections involved in the high fructose and high fat diet induced diabetes associated nonalcoholic fatty liver disease. Inflammation Research. 69(9). 851–867. 16 indexed citations

11.

Bedi, Onkar, et al.. (2020). Role of Microbiota in Pathogenesis and Management of Viral Hepatitis. Frontiers in Cellular and Infection Microbiology. 10. 341–341. 39 indexed citations

12.

Bedi, Onkar, et al.. (2020). In vitro targeted screening and molecular docking of stilbene, quinones, and flavonoid on 3T3-L1 pre-adipocytes for anti-adipogenic actions. Naunyn-Schmiedeberg s Archives of Pharmacology. 393(11). 2093–2106. 14 indexed citations

13.

Bedi, Onkar & Pawan Krishan. (2019). Investigations on acute oral toxicity studies of purpurin by application of OECD guideline 423 in rodents. Naunyn-Schmiedeberg s Archives of Pharmacology. 393(4). 565–571. 37 indexed citations

14.

Bedi, Onkar, et al.. (2018). Molecular and Pathological Events Involved in the Pathogenesis of Diabetes-Associated Nonalcoholic Fatty Liver Disease. Journal of Clinical and Experimental Hepatology. 9(5). 607–618. 60 indexed citations

15.

Krishan, Pawan, Onkar Bedi, & Monika Rani. (2017). Impact of diet restriction in the management of diabetes: evidences from preclinical studies. Naunyn-Schmiedeberg s Archives of Pharmacology. 391(3). 235–245. 7 indexed citations

16.

Krishan, Pawan, Gaaminepreet Singh, & Onkar Bedi. (2017). Carbohydrate restriction ameliorates nephropathy by reducing oxidative stress and upregulating HIF-1α levels in type-1 diabetic rats. Journal of Diabetes & Metabolic Disorders. 16(1). 47–47. 21 indexed citations

17.

Bedi, Onkar, et al.. (2015). Anti-hyperalgesic and anti-nociceptive potentials of standardized grape seed proanthocyanidin extract against CCI-induced neuropathic pain in rats. Journal of Basic and Clinical Physiology and Pharmacology. 27(1). 9–17. 21 indexed citations

18.

Bedi, Onkar, et al.. (2015). Animal models of hepatotoxicity. Inflammation Research. 65(1). 13–24. 39 indexed citations

19.

Kaur, Manpreet, et al.. (2015). Combined effect of hydrogen sulphide donor and losartan in experimental diabetic nephropathy in rats. Journal of Diabetes & Metabolic Disorders. 14(1). 63–63. 16 indexed citations

20.

Kaur, Manpreet, et al.. (2014). Rodent animal models: from mild to advanced stages of diabetic nephropathy. Inflammopharmacology. 22(5). 279–293. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact